Puerto Rico vs Sur: Previously treated cases tested for RR-/MDR-TB
Puerto Rico
100.0%
in 2023
Sur
62.0%
in 2024
Puerto Rico rank
1st
Sur rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Puerto Rico
- Sur
How they compare
Puerto Rico currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Puerto Rico's figure about 1.6 times Sur's.
The two have swapped places 3 times across 7 shared years of data; in 2012 it was Puerto Rico ahead.
Puerto Rico ranks 1st and Sur ranks 2nd of 180 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Puerto Rico | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 85.0% | 56.4% | 28.6% | Puerto Rico |
| 2020s | 100.0% | 94.0% | 6.0% | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Puerto Rico or Sur?
- Puerto Rico, at 100.0% against 62.0% in Sur as of 2023.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Puerto Rico and Sur?
- 38.0%, with Puerto Rico ahead.
- How many years of comparable data are there for Puerto Rico and Sur?
- 7 years are reported by both, from 2012 to 2023.
- How do Puerto Rico and Sur rank globally for previously treated cases tested for rr-/mdr-tb?
- Puerto Rico ranks 1st and Sur ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.